These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1209784)

  • 1. Electrocardiographic changes during the first few seconds after cardioversion of atrial fibrillation and flutter.
    Furberg B; Malmström C; Sundlöf G
    Ups J Med Sci; 1975; 80(3):127-30. PubMed ID: 1209784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elective cardioversion in the presence of conduction disturbances.
    Cascio WE; Foster JR; Sheps DS
    J Electrocardiol; 1984 Jan; 17(1):63-6. PubMed ID: 6230411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial energy setting, outcome and efficiency in direct current cardioversion of atrial fibrillation and flutter.
    Gallagher MM; Guo XH; Poloniecki JD; Guan Yap Y; Ward D; Camm AJ
    J Am Coll Cardiol; 2001 Nov; 38(5):1498-504. PubMed ID: 11691530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic markers of cardioversion success in patients with atrial fibrillation or flutter.
    Heston TF; Cheng A
    South Med J; 2009 Sep; 102(9):877-8. PubMed ID: 19668046
    [No Abstract]   [Full Text] [Related]  

  • 5. Low energy synchronous transcatheter cardioversion of atrial flutter/fibrillation in the dog.
    Kumagai K; Yamanouchi Y; Tashiro N; Hiroki T; Arakawa K
    J Am Coll Cardiol; 1990 Aug; 16(2):497-501. PubMed ID: 2373830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of cardioversion in sinus rhythm on the systolic dynamics in atrial fibrillation and flutter].
    Ungureanu G; Cosovanu A; Hurmuzache ME
    Rev Med Chir Soc Med Nat Iasi; 1990; 94(1):57-66. PubMed ID: 2075336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arrhythmia following immediately after cardioversion of auricular fibrillation and auricular flutter].
    Wink K; Hager W
    Z Kreislaufforsch; 1971 Apr; 60(4):318-29. PubMed ID: 5578072
    [No Abstract]   [Full Text] [Related]  

  • 8. Atrial defibrillation voltage: falling to a new low.
    Trayanova N
    Heart Rhythm; 2011 Jan; 8(1):109-10. PubMed ID: 21044899
    [No Abstract]   [Full Text] [Related]  

  • 9. [Success of pharmacologic cardioversion and electric cardioversion in patients with atrial fibrillation or flutter in a 5-year retrospective study].
    Bugán V; Renker B; Brunclík P; Baraniková D; Augustín E
    Vnitr Lek; 1994 Apr; 40(4):219-22. PubMed ID: 8184582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transesophageal low-energy synchronous cardioversion of atrial flutter/fibrillation in the dog.
    Yamanouchi Y; Kumagai K; Tashiro N; Hiroki T; Arakawa K
    Am Heart J; 1992 Feb; 123(2):417-20. PubMed ID: 1736579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1:1 atrial flutter after vernakalant administration for atrial fibrillation cardioversion.
    de Riva-Silva M; Montero-Cabezas JM; Salgado-Aranda R; López-Gil M; Fontenla-Cerezuela A; Arribas-Ynsaurriaga F
    Rev Esp Cardiol (Engl Ed); 2012 Nov; 65(11):1062-4. PubMed ID: 22727797
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electrocardiographic diagnosis and acute treatment of atrial fibrillation and flutter episodes].
    Pastor Fuentes A; Esteban Paúl E; Montero MA; García Baró B; López Bescós L
    Rev Esp Cardiol; 1996; 49 Suppl 2():22-31. PubMed ID: 8755693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation in therapy of patients with atrial fibrillation or flutter.
    Waldo AL
    Cardiol Clin; 1990 Aug; 8(3):479-90. PubMed ID: 2205386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the efficacy and safety of electrical cardioversion and pharmacological cardioversion with nibentan in patients with persisting atrial fibrillation and flutter].
    Giliarov MIu; Novikova NA; Sulimov VA; Suchkova SA; Syrkin AL
    Vestn Ross Akad Med Nauk; 2007; (5):22-6. PubMed ID: 17601037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis.
    Berger M; Schweitzer P
    Am J Cardiol; 1998 Dec; 82(12):1545-7, A8. PubMed ID: 9874066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmic complications of electrical cardioversion: relationship to shock energy.
    Gallagher MM; Yap YG; Padula M; Ward DE; Rowland E; Camm AJ
    Int J Cardiol; 2008 Jan; 123(3):307-12. PubMed ID: 17395302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of pad placement for electrical cardioversion of atrial fibrillation/flutter: a systematic review.
    Kirkland S; Stiell I; AlShawabkeh T; Campbell S; Dickinson G; Rowe BH
    Acad Emerg Med; 2014 Jul; 21(7):717-26. PubMed ID: 25117151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial function after cardioversion.
    Rowlands DJ; Logan WF; Howitt G
    Am Heart J; 1967 Aug; 74(2):149-60. PubMed ID: 4951291
    [No Abstract]   [Full Text] [Related]  

  • 19. [Physiopathology and pathophysiology of excitation in the human heart. Findings in electrotherapy of heart rhythm disturbances].
    Büchner M
    Arch Kreislaufforsch; 1969; 60(3):327-63. PubMed ID: 4915259
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of atrial fibrillation and flutter].
    Fazekas T
    Orv Hetil; 2003 Aug; 144(34):1687-9. PubMed ID: 14528843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.